criteria for Titration of atropine based on clinical symptoms of organophosphorus poisoning patients
- Conditions
- Health Condition 1: T78- Adverse effects, not elsewhere classified
- Registration Number
- CTRI/2021/02/031201
- Lead Sponsor
- Ashwini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients admitted with Organophosphorus poisoning in the intensive care unit of Kasturba hospital Manipal.
2.Organophosphorus poisoning patients those who are on treatment with injection Atropine infusion.
3.Organo phosphorus poisoned patients above 18 years and who are willing to participate in the study by giving informed consent.
1.Organophosphorus poisoning patients those who are not on treatment with injection atropine infusion
2.Organophosphorus poisoned Patients less than 18 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method measures: It includes Mortality,clinical symptoms, number of days of ICU,number of days of Hospitalization.Timepoint: measures: It includes Mortality, number of days in ICU, clinical symptoms, number of days Hospitalization.
- Secondary Outcome Measures
Name Time Method sefulness of parameters in titration of atropine and patient outcome in organophosphorus poisoningTimepoint: at baseline